|Market Cap (Intraday)||1.72B|
|2yr Forward PE||N/A|
uniQure N.V. Stock, NASDAQ:QURE
uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.